The Trump Food and Drug Administration (FDA) quietly approved a new abortion drug just days after announcing a review of mifepristone—the pill responsible for ending millions of preborn lives and endangering countless women.
This move comes after several states urged the FDA to investigate the dangerous abortion pill regimen that the abortion industry has recklessly promoted for over two decades.
The pill mifepristone, often paired with misoprostol, starves a preborn child of nutrients before expelling him or her from the mother’s womb. These pills are marketed as “safe” and “effective” by abortion activists, but in reality, they are extremely harmful.
Earlier this year, the Ethics and Public Policy Center released shocking findings: one in ten women who take chemical abortion pills ends up in the emergency room. This data confirms what Pro-Life advocates have warned for years—chemical abortions are not only deadly for the baby, but dangerous for the mother.
The FDA first approved mifepristone in 2000 under heavy political pressure, ignoring mounting evidence of complications, trauma, and even maternal deaths.
Since then, anti-Life activists have fought tirelessly to loosen safety requirements, allowing abortion pills to be sold through mail-order and telehealth schemes. Now, these drugs can even be mailed without any in-person doctor visits—putting women at serious risk.
Story continues below.
Don’t miss important Pro-Life stories like this.
>> Get the Pro-Life Weekly Highlight just once a week:
Beyond this, the FDA only requires deaths to be reported as negative outcomes, leaving countless complications unreported and giving the public a false sense of safety about abortion pills.
A thorough review of mifepristone is long overdue. States like Texas have already passed strong laws to block the mailing of abortion pills and to hold the abortion industry accountable for endangering women.
Now, before even completing their review of the drug, the FDA is adding a cheaper version of the same drug to the market. The new manufacturer, Evita Solutions, openly states its mission to “normalize abortion” and make it “accessible to all.”
Abortion is the leading cause of death in America. The FDA must end the sale of all abortion drugs for the purpose of killing preborn children. Banning abortion pills could spare 600,000 babies and countless women from devastation every year.
Abortion pills leave women isolated, bleeding, and traumatized—often alone in their bathrooms or dorm rooms while enduring a violent process that ends their child’s life.
These pills also make it easier for human traffickers and abusive partners to harm women without their knowledge, as seen in recent tragic cases in Texas. Unlike surgical abortion, chemical abortion shifts nearly all the trauma and risk onto the mother, with little to no follow-up care or support.
This week, 51 members of Congress sent a letter to FDA Secretary Kennedy and Commissioner Makary, highlighting evidence showing that complications from abortion pills are more than 22 times higher than the FDA currently reports. The letter also urges the agency to reconsider its approval of the generic version of mifepristone and to reinstate the in-person distribution requirement—critical safeguards that protect women from the dangers of chemical abortion.
Along with these leaders, Texas Right to Life condemns the Trump administration’s rushed approval of a new abortion pill, and asks them to not only undo this, but also evaluate the abortion pill, mifepristone. Americans deserve leaders who protect women and children, not abortion profits. Every death of a preborn child—and every woman harmed—is a preventable tragedy. The FDA must face reality: abortion pills are deadly, dangerous, and their reckless distribution must end.
Thank you for reading this story! If you support our Pro-Life ministry, chip in with a life-saving contribution today!
